DexCom gets FDA approval for blood-sugar monitoring system

By Elaine Rigoli

Tampa, Fla., March 27 - DexCom, Inc. has received Food and Drug Administration approval for its STS Continuous Glucose Monitoring System, designed to help diabetics manage their blood sugar levels.

The DexCom STS consists of a tiny wire-like sensor that is inserted by the patient just under the skin, according to a news release.

The sensor continuously measures glucose levels, which are transmitted wirelessly to the cell phone-like STS receiver.

With the push of a button, the handheld receiver provides the patient with real-time glucose measurements and trends, as well as providing alerts to warn of high and low glucose levels, the release said.

Diabetes is a chronic disease with no known cure and which afflicts about 20 million people in the United States, according to the Centers for Disease Control and Prevention.

In the United States, diabetes is the leading cause of adult blindness, end stage kidney failure and lower limb amputations. People suffering from diabetes are also more significantly at risk for cardiovascular disease and stroke.

DexCom, based in San Diego, develops technology to continuously monitor glucose levels in people with diabetes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.